Company
Headquarters: Seattle, WA, United States
CEO: Dr. James N. Topper M.D., Ph.D.
$337.5 Million
USD as of Jan. 1, 2025
Company | Market Cap (USD) |
---|---|
Berkshire Hathaway | $991.39 B |
JPMorgan | $744.02 B |
Visa | $635.57 B |
Mastercard | $490.32 B |
Bank of America | $353.07 B |
Frazier Lifesciences Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or related business combination with one or more businesses or entities in the biotechnology sector. The company was incorporated in 2020 and is based in Seattle, Washington.
Frazier Lifesciences Acquisition Corp has the following listings and related stock indices.
Stock: NASDAQ: FLAC wb_incandescent